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Based on considered achievements of the last 25 years, specific combinations of sulfation
patterns and glycosylation types have been proved to be key structural players for
the anticoagulant activity of certain marine glycans. These conclusions were obtained
from comparative and systematic analyses on the structure-anticoagulation relationships
of chemically well-defined sulfated polysaccharides of marine invertebrates and red
algae. These sulfated polysaccharides are known as sulfated fucans (SFs), sulfated
galactans (SGs) and glycosaminoglycans (GAGs). The structural combinations necessary
for the anticoagulant activities are the 2-sulfation in α-L-SGs, the 2,4-di-sulfation in
α-L-fucopyranosyl units found as composing units of certain sea-urchin and sea-cucumber
linear SFs, or as branching units of the fucosylated chondroitin sulfate, a unique GAG from
sea-cucumbers. Another unique GAG type from marine organisms is the dermatan sulfate
isolated from ascidians. The high levels of 4-sulfation at the galactosamine units combined
with certain levels of 2-sulfation at the iduronic acid units is the anticoagulant structural
requirements of these GAGs. When the backbones of red algal SGs are homogeneous, the
anticoagulation is proportionally dependent of their sulfation content. Finally, 4-sulfation
was observed to be the structural motif required to enhance the inhibition of thrombin via
heparin cofactor-II by invertebrate SFs.
Keywords: algae, carbohydrate-based drug development, fucosylated chondroitin sulfate, sea cucumber, sea
urchin, sulfated galactan, sulfated fucan
INTRODUCTION
Marine organisms represent a very special source of potential
therapeutic molecules with unique structures. Among innumer-
ous of these compounds, the sulfated polysaccharides (SPs) have
awakened great interest in the scientific community. This happens
mostly because of the fact that these compounds hold the charac-
teristic of being naturally polyanionic. This feature makes the SPs
suitable to interact with important functional proteins, especially
those involved in the balance of health and disease. The nature
and quality of the SP-protein interactions control and regulate
the activity of these functional proteins in the body. Although
the affinity of these molecular complexes are mostly driven by
electrostatic interactions in which sulfation content of the SPs
play a crucial role, the overall structural features of the SPs are
still more influential in the process (Pomin, 2009). The structural
features of the SPs involved into the quality of these molecu-
lar interactions are sulfation patterns and glycosylation. This
latter includes anomeric and enantiomeric configurations,
Abbreviations: aPTT, activated partial thromboplastin time; AT, antithrombin;
DS, dermatan sulfate; Fucp, L-fucopyranose; FucCS, fucosylated chondroitin sul-
fate; GAGs, glycosaminoglycans; GalNAc, N-acetyl D-galactosamine; Galp, galac-
topyranose; GlcA, D-glucuronic acid; HCII, heparin cofactor II; IdoA, L-iduronic
acid; MSPs, marine sulfated polysaccharides; SGs, sulfated galactans; SFs, sulfated
fucans; SPs, sulfated polysaccharides; UFH, unfractionated heparin; IIa, thrombin;
XIIa, factor XII activated.
glycosidic linkage position, monosaccharide type and
composition.
In the last 25 years, our group has made great efforts in
scientific researches related with marine and medicinal glycobi-
ology. As a consequence, many sulfated fucans (SFs), sulfated
galactans (SGs) and glycosaminoglycans (GAGs) of new struc-
tures have been characterized and described (Vieira and Mourão,
1988; Mourão, 2004; Pomin and Mourão, 2008). We believe
that we have fully characterized over 20 new structures of these
marine sulfated polysaccharides (MSPs) in our studies (Vieira and
Mourão, 1988; Mourão, 2004; Pomin and Mourão, 2008; Pomin,
2009, 2012a,b, 2014a,b). We have also submitted most of these
new MSPs to in vitro experiments to assess their possible antico-
agulant effects (Mourão, 2004; Pomin and Mourão, 2008; Pomin,
2009). Curiously, we noticed that even though bearing significant
levels of sulfation, some of these MSPs have insignificant effects
toward the coagulation system; while other MSPs, even carrying
lower sulfation content, can show surprising levels of anticoagu-
lant activity (Mourão, 2004; Pomin, 2009). Moreover, some SFs
and SGs, even though exhibiting nearly equal sulfation levels, but
within different sulfation patterns, have completely different anti-
coagulant effects. This observation has clearly proved the concept
that sulfation and thus electronegative-charge density in marine
carbohydrates are not the solely structural determinants for the
resultant anticoagulant activities of these molecules.
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Since we have characterized and used many different struc-
tures in our anticoagulant tests across the last years, we should
be able to state by now some of the structural features of the
MSPs necessary for their differential anticoagulant properties.
Based on comparative and systematic analyses on the structure-
anticoagulation relationships of certain MSPs, we noticed that to
achieve a good anticoagulant response, certain structural com-
binations of sulfation and glycosylation are indeed required.
In these analyses, we have particularly given more preference
to examine SFs, SGs and GAGs from marine invertebrates or
red algae, since these organisms can provide molecules of well-
defined chemical structures (Mourão, 2004; Pomin, 2009, 2012c;
Pomin and Mourão, 2012). This kind of structural regularity has
facilitated interpretation and this in turn enables us to establish
advanced structure-anticoagulation relationships (Pereira et al.,
2002; Pomin, 2009, 2012c). Here, we describe based on data of
some of our previous works, the major structural combinations
of the invertebrate and red algal MSPs that have been proved to
be necessary to make a satisfactory anticoagulant effect.
THE ROLE OF SFs AND SGs OF WELL-DEFINED STRUCTURES: ALGAL vs.
INVERTEBRATE MOLECULES
SFs are a class of SPs composed mostly of α-L-fucopyranosyl
(Fucp) units. SFs can be extracted mostly frommarine organisms,
such as sea-urchins (echinoidea), sea-cucumbers (holothuroidea)
and brown algae (phaeophyta). These molecules are also known
as fucoidans when isolated from brown algae. Besides Fucp, the
fucoidans are also composed of other sugars, such as xylose
and uronic acids. This heterogeneous monosaccharide compo-
sition, associated with the lack or an unclear structural pattern
of regularity and the presence of branching residues, makes the
establishment of the structure-function relationships for algal
molecules very hard (Pereira et al., 1999). On the other hand,
the SFs isolated from invertebrates can reveal structures quite
regular (Figures 1A–I). This type of structural pattern helps
to achieve advanced structure-function correlations about their
anticoagulant properties. Using the invertebrate SFs, we are able
to understand which structural features are important for the
anticoagulant activity of these molecules (Pereira et al., 1999;
Pomin, 2009, 2012b,c). Below, some of these influential structural
features on coagulation of the MSPs of well-defined chemical
structures will be described.
SGs are a class of SPs composed of α-L-, α-D-, or β-D-
galactopyranosyl (Galp) units. SGs can be found in green algae
(clorophyta), red algae (rodophyta), sea-urchins and ascidians
which are also known as tunicates (ascidiacea). Like SFs, algal
SGs have structures more complex than the regular and simpler
invertebrate counterparts. In green algae, for example, the sulfa-
tion pattern is usually complex, with additional substitutions like
pyruvates, and the possibility of branches (Farias et al., 2008). In
red algae, although the SGs show heterogeneous sulfation pat-
terns, they are usually composed of disaccharide repeating units
of 3-linked β-D-Galp and 4-linked α-Gal units in their back-
bones. Sometimes, the latter unit can be seen forming an extra
carbon ring which results in an anhydro-sugar (Quinderé et al.,
2014). This is an additional heterogeneity that enhances struc-
tural complexity in the red algal molecule. However, some red
algal species can show very simple structures whose sulfation pat-
terns vary accordingly to the species of extraction. Two examples
of these structures are shown at panels N and O of Figure 1.
Advanced structure-function correlations can be reached when
these red algal SGs are used, as opposed to the more heteroge-
neous SGs from red or green algae. Conversely, the invertebrate
SGs are very often composed of well-defined chemical struc-
tures (Figures 1J–M), which allow accurate structure-function
correlations.
The information in the two previous paragraphs have made
clear the advantages of the structures of the invertebrate SFs
and SGs over the algal molecules, except few cases of red algal
molecules (Figures 1N,O). These advantages come from the fact
that the invertebrate molecules and the regular red algal SGs
(Figure 1), which are composed of well-defined chemical struc-
tures, can be successfully used in structure-function relationship
studies (Table 1). These studies allow prediction of the most
influential structural combinations of the MSPs to achieve desir-
able anticoagulant responses. This knowledge is relevant to the
development of these molecules as future therapeutic candidates.
MARINE GAGs HAVE UNIQUE STRUCTURES
Marine GAGs have different structures than those present in
common mammal GAGs. For example, dermatan sulfate (DS)
isolated from the ascidian species Styela plicata is composed
of [→4)-α-L-IdoA-(2R1,3R2)-(1→3)-β-D-GalNAc-(4R3,6R4)-
(1→]n, where IdoA is iduronic acid, GalNAc is N-acetyl
galactosamine. The R1, R2, R3, and R4 are sulfate groups at 66,
< 5, 94, and 6 percent, respectively (Pavão et al., 1998). The S.
plicata is mostly 2-sulfated at the IdoA unit but largely 4-sulfated
at the GalNAc unit. Conversely, the commonest mammalian
DS is mostly composed of 2-sulfated IdoA units together with
occasional C4 sulfation at GalNAc units. Another different GAG
from marine invertebrates is the fucosylated chondroitin sulfate
(FucCS) isolated from sea-cucumbers. These molecules are
composed of the following structure {→3)-β-D-GalNAc-(1→4)-
[α-L-Fucp-(1→3)]-β-D-GlcA-(1→}n (Figure 2) (Pomin,
2014a). The branching Fucp unit can be sulfated at the 2, and/or
3 and/or 4-positions within different percentages according to
the species of occurrence (Table 2). Conversely, the commonest
chondroitin sulfates (CSs) of mammals are made of the following
structure [→4)-β-D-GlcA-(1→3)-β-D-GalNAc-(1→]n, in
which the GalNAc units can be either mostly 4-sulfated (CS-A)
or predominantly 6-sulfated (CS-C) (Pomin et al., 2012).
ANTICOAGULANT MECHANISMS OF ACTION OF THE MSPs
The effects of MSPs on hemostasis are the mostly studied med-
ical activities of these compounds. The mechanisms of action in
this particular clinical activity reside basically on the inhibition of
some coagulation proteases like thrombin citation(IIa) and factor
Xa, via their natural inhibitors, named serpins citation(serine-
protease inhibitors). The most common serpins of this system
are antithrombin citation(AT) and heparin cofactor II cita-
tion(HCII). Although at different degrees of response, the major-
ity of the MSPs described in this review, the ascidian DS (Pavão
et al., 1998; Vicente et al., 2004; Kozlowski et al., 2011), the sea-
cucumber FucCS (Mourão et al., 1996; Mourão, 2004), the algal
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FIGURE 1 | Structural representation of the repetitive oligomeric
units of the SFs (A–I) and SGs (J–O, inside the box) of
well-defined chemical structures isolated from cell wall of sea
cucumbers (A), from egg jelly coat of sea urchins (B–K),
from tunic of ascidians (L,M), and from cell wall of red
algae (N,O). Modified with permission from Pomin (2012b). These
MSP are composed of α-L-fucopyranoses (α-l-Fucp) (A–I),
α-L-galactopyranoses (α-L-Galp) (I, M-O), or β-D-galactopyranosyl units
(β-D-Galp) (K,N,O). The species-specific structures vary in sulfation
patterns (exclusively 2-O- and/or 4-O-, or 3-O-positions), in
glycosidic linkages: α(1→3) (A–C,E,F,H–K), α(1→4) (D,G,L,M),
β(1→3) (K), or alternating β(1→4) and α(1→3) (N,O); and in
number of composing residues of the repetitive units:
tetrasaccharides (A–D), trisaccharides (F), disaccharides (K,N,O), or
monosaccharides (E,G–J,L), all in linear chains, except (M). The
sulfation groups are highlighted by red dashed ellipses or
rectangle when just percentage can be estimated. The structures
are the following: (A) Ludwgothurea grisea
[→3)-α-L-Fucp-2,4(OSO3−)-(1→3)-α-L-Fucp-(1→3)-α-L-Fucp-2(OSO3−)-(1→3)-α-
L-Fucp-2(OSO3−)-(1→]n (Mulloy et al., 1994); (B) Lytechinus
variegates I [→3)-α-L-Fucp-2,4(OSO3−)-(1→3)-α-L-Fucp-2(OSO3−)-(1→3)-α-
L-Fucp-2(OSO3−)-(1→3)-α-L-Fucp-4(OSO3−)-(1→]n (Mulloy et al.,
1994); (C) Strongylocentrotus pallidus [→3)-α-L-Fucp-4(OSO3−)-(1→3)-α-
L-Fucp-4(OSO3−)-(1→3)-α-L-Fucp-2(OSO3−)-(1→3)-α-L-Fucp-2(OSO3−)-(1→]n
(Vilela-Silva et al., 2002); (D) Arbacia lixula [→4)-α-L-Fucp-2(OSO3−)-
(1→4)-α-L-Fucp-2(OSO3−)-(1→4)-α-L-Fucp-(1→4)-α-L-Fucp-(1→]n (Alves
et al., 1997); (E) Strongylocentrotus purpuratus I ∼80%
[→3)-α-L-Fucp-2,4(OSO3−)-(1→]nand ∼20%
[→3)-α-L-Fucp-2(OSO3−)-(1→]n(Alves, Mulloy, Moy, Vacquier and
Mourão, 1998) and (F) S. purpuratus II [→3)-α-L-Fucp-2,4(OSO3−)-
(1→3)-α-L-Fucp-4(OSO3−)-(1→3)-α-L-Fucp-4(OSO3−)-(1→]n (Alves, Mulloy,
Moy, Vacquier and Mourão, 1998); Strongylocentrotus
droebachiensis [→4)-α-L-Fucp-2(OSO3−)-(1→]  (n Vilela-Silva et al., 2002);
(H) Strongylocentrotus franciscanus [3)-α-L-Fucp-2(OSO3−)-(1→]n
(Vilela-Silva et al., 1999); (I) L. varieagtus II
[3)-α-L-Fucp-4(OSO3−)-(1→]n (Cinelli et al., 2007); (J) Echinometra
lucunter [→3-α-L-Galp-2(OSO3−)-1→]n (Alves et al., 1997); (K)
Glyptocidaris crenularis [→3-β-L-Galp-2(OSO3−)-1→3-β-L-Galp-1→]n (Castro
et al., 2009); (L) Herdmania monus [→4)-α-L-Galp-3(SO3−)-(1→]n
(Santos et al., 1992); (M) Styela plicata {→4)-α-L-Galp-2[→1)-
α-L-Galp-3(OSO3−)]-3(OSO3−)-(1→}  (n Mourão and Perlin, 1987); (N,O)
both Botriocladia occidentalis and Gelidium crinale express
structures of [3-β-D-Galp-1→4-α-Gal-1→]nwith different sulfation
contents (Farias et al., 2000; Pereira et al., 2005b).
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Table 1 | Anticoagulant activities of MSPs of well-defined structures (Figure 1) measured by aPTTa and by IC50for thrombin citation(IIa) and
factor Xa inhibition in the presence of antithrombin citation(AT) or heparin cofactor II (HCII).
Polysaccharide Source Structure (Figure) APTTcitation(IU/mg) a IC50 citation(µg/mL)
IIa/AT IIa/HCII Xa/AT
3-linked sulfated α-L-fucans S. purpuratus I 1E 76 0.3 0.3 2
S. purpuratus II 1F 10 0.9 2 Ndb
S. pallidus 1C 18 >500 >500 >500
L. variegatus I 1B 3 >500 >500 >500
L. variegatus II 1I Nd Nd Nd Nd
S. franciscanus 1H ∼2 >500 >500 250
L. grisea 1A <1 >500 >500 >500
4-linked sulfated α-L-fucans S. droebachiensis 1G <1 Nd Nd Nd
A. lixula 1D ∼2 150 150 >500
sulfated α-L-galactans E. lucunter 1J 20 3 6 20
G. crenularis 1K Nd Nd Nd Nd
H. monus 1L ∼2 >500 >500 >500
S. plicata 1M <1 >500 >500 >500
algal SGs B. occidentalis 1N 93 0.02 1.1 2.5
G. crinale 1O 65 0.02 25 1.5
Modified with permission from Pomin (2009).
aThe activity is expressed as international units/mg using a parallel standard curve based on the International Heparin Standard citation(193 units/mg).
bNot determined.
FIGURE 2 | Structural representation of the holothurian FucCS. The
monosaccharides are indicated by rectangles. They are α-l-fucopyranose
(l-Fucp), β-d-glucuronic acid (d-GlcA), and N-acetyl β-d-galactosamine
(d-GalNAc). The glycosidic linkage types are indicated in ellipses. Modified
with permission from Pomin (2014a).
SFs and SGs (Pereira et al., 1999; Farias et al., 2000; Mourão,
2004) and the invertebrate SFs and SGs (Pereira et al., 1999,
2002; Pomin, 2012c) have either negligible or impressive effects
in this serpin-dependent mechanism. The resultant anticoagulant
activities of theseMSPs (Tables 1, 2) are intimately and ultimately
dependent on their structural features, as described below.
Besides the common serpin-dependent anticoagulant mech-
anism, the FucCS from the sea-cucumber Ludwigothurea grisea,
which its fucosyl unit is mostly 2,4-di-sulfated (Figure 2;Table 2),
and the SG from the red alga Botryocladia occidentalis (Figure 1N)
have also shown serpin-independent anticoagulant mechanism
(Glauser et al., 2008, 2009). Initially, their anticoagulant actions
were primarily attributed by their capacity in potentiate the inhi-
bition of factors Xa and IIa, via either AT or HCII. However,
the sea-cucumber FucCS and the red algal SG are also known
to inhibit the generation of factor Xa and IIa by interfering in
the formation of the blood cofactor complexes at the surface of
the cells. Factor Xa is activated mainly by the intrinsic tenase
complex, while IIa is converted from II by the prothrombinase
complex. FucCS and SG were shown the ability to inhibit the acti-
vation of these tenase and prothrombinase complexes (Glauser
et al., 2008, 2009). The formation of these complexes is a key
step for the generation and amplification of the coagulation cofac-
tors. This serpin-independent mechanism has also been reported
for other types of SGs (Quinderé et al., 2014). Unfortunately,
advanced structure-function correlations are yet to be established
for this novel mechanism. Therefore, the structural requirements
necessary to achieve the anticoagulant activity via the serpin-
independent mechanism are still unknown. For this reason, we
will keep this new anticoagulant mechanism out of discussion
here.
THE ANTICOAGULANT STRUCTURAL COMBINATIONS
The anticoagulant structural features responsible for the antico-
agulant activity of the MSPs can be determined from systematic
analyses using the MSPs of well-defined chemical structures
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Table 2 | Sulfation patterns (proportions of the branching sulfated fucose units) and the anticoagulant potential (measured by aPTT) of FucCS
from 12 sea cucumber species analyzed so far.
Species Fuc0S Fuc3S Fuc4S Fuc2S4S Fuc3S4S aPTT References
Ludwigothurea griseaa 0 - ∼49 ∼20 ∼17 55b Mourão et al., 1996; Fonseca et al., 2009
Pearsonothuria graeffei - - 81.6 18.4 - 35c Chen et al., 2011
Holothuria vagabunda 25.6 - 50.2 15.8 8.4 42c Chen et al., 2011
Stichopus tremulus - - 24.8 22.4 52.8 135c Chen et al., 2011
Isostichopus badionotus - - 4.1 95.9 - 183c Chen et al., 2011
Thelenata ananas 0 ∼25 ∼22 ∼53 0 348d Wu et al., 2010, 2012
Stichopus japonicuse 0 Ndf 11.1 55.6 33.3 Nsg Yoshida and Minami, 1992
Holothuria edulish - - Nd 18 Nd 89i Luo et al., 2013
Apostichopus japonicash - - Nd 45 Nd 116i Luo et al., 2013
Holothuria nobilisj - Nd Nd - Nd 59i Luo et al., 2013
Acaudina molpadioideak - - - - - Ncl Ye et al., 2012
Athyonidium chilensisk - - - - - Ncl Matsuhiro et al., 2012
Reprint with permission from Pomin (2014a).
aThe CS backbone of FucCS from L. grisea has been extensively characterized. It is composed of GalNAc units with the following substitution percentages: 12%
4,6-di-sulfated, 53% 6-mono-sulfated, 4% 4-mono-sulfated, and 31% non-sulfated (Fonseca et al., 2009).
baPTT values expressed as international units/mg citation(IU/mg) using a parallel standard curve based on the International Heparin Standard (UFH) whose activity
is 229 units/mg (Fonseca et al., 2009).
caPTT values expressed as international units/mg citation(IU/mg) using a parallel standard curve based on the International Heparin Standard citation(UFH) whose
activity is 150 units/mg (Chen et al., 2011).
d aPTT values expressed as international units/mg citation(IU/mg) using a parallel standard curve based on the International Heparin Standard citation(UFH) whose
activity is 204 units/mg (Wu et al., 2012).
eThe CS backbone of this FucCS was mostly characterized as CS-E (Nagase et al., 1995), which is predominantly composed of 4,6-O-di-sulfated GalNAc units.
f Not determined.
gNot studied.
hAlthough the mono-4S and di-3S4S fucosyl units have been assigned in the FucCS of H. edulis and A. japonicas in Luo et al. (2013), the amounts of these units
were not provided therein.
i aPTT values expressed as international units/mg citation(IU/mg) using a parallel standard curve based on the International Heparin Standard citation(UFH) whose
activity is 212 units/mg (Luo et al., 2013).
j The FucCS from H. nobilis was studied by NMR but the anomeric signals belonging to the fucose residues were rather to weak and broad to allow integration and
further quantitation of their proportions. However, mono-3S, mono-4S, and di-3S4S fucosyl units were clearly observed (Luo et al., 2013).
k Structures studied by Fourier transformed-infrared spectroscopy. Just a few structural features were raised. The sulfation patterns of FucCS from these two
holothurian species are still an unknown.
l Not clear. Although the aPTT assay was undertaken and values were measured for different FucCSs concentration, the final values in IU/mg in comparison with a
standard UFH curve were not provided.
(Figure 1). On this way, comparing all the structures in Figure 1,
one can discern structural similarities and differences in these
molecules. For example, both the SF from Strongylocentrotus
franciscanus (Figure 1H), and the SG from Echinometra lucunter
(Figure 1J) present the same sulfation pattern (exclusive and
entirely 2-sulfated), the same anomeric configuration (α-form),
the same glycosidic linkage (1→3), and based on previous works
(Pereira et al., 2005a), the same molecular mass (∼100 kDa).
Their single difference is the sugar type (Fucp or Galp).
Interestingly, this single structural difference is itself enough to
promote great changes in the anticoagulant outcomes of these
homopolysaccharides. The 2-sulfated α-galactan from E. lucunter
exhibits a significant anticoagulant activity monitored by the
activated partial thromboplastin time (aPTT) method (Pomin,
2014b). The anticoagulant potential of this SG was determined
to be 20 IU mg, although almost 10-fold less than unfractionated
heparin (UFH) (Table 1). The specific anticoagulant assay with
the purified proteases revealed that this SG enhances both IIa and
factor Xa inhibition by either AT or HCII (Table 1). Conversely,
the anticoagulant effect of 2-sulfated α-fucan from S. franciscanus
is exclusively based on catalysis of AT inhibition over factor Xa,
although it is 12.5-fold less active than the α-SG. This single effect
on the Xa/AT system explains the much lower activity of the com-
pound from S. franciscanus (aPTT of ∼2 IU mg−1, 100-fold less
active than UFH) since the anti-Xa activity has a relatively minor
influence on the aPTT. This is an illustrative and typical exam-
ple of a sugar-type-dependent biological effect of polysaccharides.
The structural combination of 2-sulfation with 3-linked α-Galp
units results therefore in the anticoagulant response.
Based on this same systematic and comparative analy-
sis, the SGs from the red algae Botryocladia occidentalis and
Gelidium crinale were seen to exhibit identical backbones, and
the same chain sizes (Farias et al., 2000; Pereira et al., 2005b).
However, there are slight differences in their sulfation patterns
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(Figures 1M,O). As summarized in Table 1, these structural dif-
ferences account for the 30% difference in anticoagulant activity
as observed by the aPTT values of these algal macromolecules and
the even greater difference in catalytic effect of the SP from B.
occidentalis on the HCII-mediated anti-IIA activity, which was
approximately 25-fold more than the catalytic effect of the SP
from G. crinale. When the backbones of the red algal SGs are
identical but bearing sulfation as their main difference, the anti-
coagulant activity seems to be proportionally dependent of the
sulfation content (Table 1).
The structural requirements for the interaction of the MSP
of well-defined chemical structures with the coagulation cofac-
tors and their target proteases and inhibitors were determined to
be very stereospecific (Mourão, 2004; Pomin and Mourão, 2008;
Pomin, 2009). The site of sulfation has a major impact on the
activity. This can be illustrated by the fact that 2,4-di-sulfated
units have an amplifying effect on the AT-mediated anticoag-
ulant activity in the series of 3-linked α-L-fucans (Figure 1;
Table 1). Specific sulfation sites are required for the interaction
with plasma serine-protease inhibitors. Note the occurrence of
the 4-sulfated unit content in the 3-linked α-L-fucans vs. their
anticoagulant activities (Table 1). L. variegatus (a single 4-sulfated
unit/tetrasaccharide, Figure 1B, has 3 IU/mg of activity), S. pal-
lidus (a double 4-sulfated unit/tetrasaccharide, Figure 1C, has
18 IU/mg of activity), and S. purpuratus isotype II (a double 4-
sulfated unit/trisaccharide, Figure 1F, has 76 IU/mg of activity).
This 4-sulfation is the structural motif required to enhance the
inhibition of IIa by HCII. In contrast, the presence of 2-sulfated
residues seems to have a deleterious effect on HCII-mediated
anti-IIA activity of the polysaccharides (Mourão, 2004).
In the studies using the ascidian DS, Pavão and co-authors
demonstrated that 4-sulfation at GalNAc units together with
some 2-sulfation at the IdoA units is a structural motif of anti-
coagulant properties in these molecules (Pavão et al., 1998). This
was observed based on the fact that DS from the species Styela
plicata and Halocynthia pyriformis have large amounts of 4-O-
sulfated GalNac units (94 and 99%, respectively), together with
the reasonable amounts of 66 and 70% of 2-sulfation at the IdoA
units. Their anticoagulant actions were measured by aPTT and
shown to be 11 and 8 IU/mg, respectively; while the activity of
the DS from bovine mucosa was shown to be only 2 units/mg
(Pavão et al., 1998). Unlike the ascidian DSs, the mammalian DS
is largely 2-sulfated at the IdoA unit and much less sulfated at the
4-position of the GalNAc units, as above-mentioned.
The sulfated fucosyl branches in the sea-cucumber FucCS
were shown to be essential to their anticoagulant activities.
This statement is based on the fact that when these branch-
ing units are removed, for example, by mild acid hydrolysis, or
desulfated, by desulfation reactions, their anticoagulant effects
disappears (Pomin, 2014a). Besides the necessary existence of
these branching units, their sulfation patterns are also influ-
ential to the levels of anticoagulant activity. This can be seen
from the structures and aPTT values of Table 2. The 2,4-di-
sulfation in the fucosyl branching units appears to be the best
sulfation pattern to the anticoagulant activity of this class of
SPs. The importance of the 2,4-di-sulfation in Fucp units was
already pointed out in the work of Fonseca et al. (2009), as
above for the AT-mediated anticoagulant activities of the series of
3-linked α-L-fucans (Figure 1, Table 1). In the work of Fonseca
et al. (2009), the 2,4-di-sulfated Fucp units were reported to
be crucial to the anticoagulant activity of both sea-cucumber
FucCS molecules and the linear SFs from invertebrates (Figure 1,
Table 1).
MAJOR CONCLUSIONS
Here, we have made clear the relevance of certain structural
combinations of sulfation and glycosylation to the anticoagu-
lant activity of the marine carbohydrates of well-defined chemical
structures. For example, 2-sulfation together with 3-linked α-L-
Galp units, as found in the SG from the sea-urchin E. lucunter
(Figure 1J), represents one of these structural combinations.
Another combination is the 2,4-di-sulfation with α-L-Fucp units.
This combination can be found either in linear SFs of sea-urchins
and sea-cucumbers (Figures 1A,B,F), or in the branched FucCS
molecules (Figure 2, Table 2). The FucCS is a unique GAG found
exclusively in sea-cucumbers. Another unique GAG from marine
sources are the ascidian DS. For a good anticoagulant response
of these GAGs, the 4-sulfation in GalNAc units combined with
occasional 2-sulfation in IdoA units seems to be essential. When
SGs from red algae exhibit simple backbones in which sulfa-
tion comprises the single modification and difference, sulfation
content regardless the pattern seems to be relevant for the antico-
agulant activity. In this case, the anticoagulant activity increases
proportionally with the sulfation content. Finally, in inverte-
brate SFs, the 4-sulfation was observed to be a structural motif
required to enhance the HCII-mediated inhibition of IIa. All these
conclusions are summarized at Table 3 for a straightforward rep-
resentation. Although we have clearly revised the relevance of
sulfation and glycosylation to the anticoagulant activity of MSPs,
molecular weights are also known to be influential to the biolog-
ical activity (Melo et al., 2004; Quinderé et al., 2014). To ensure
that our interpretation on the anticoagulant effects of MSPs have
been based solely on sulfation and glycosylation patterns, our
comparative analyses using the different MSP structures were
Table 3 | Summary of the structural requirements and effects in
anticoagulation of the MSPs.
Structural requirement Outcome
2-sulfated 3-linked α-L-Galp a Enhance serpin (HCII and AT)
inhibitory activity over the coagulation
proteases (IIa and Xa)2,4-disulfation in Fucp
b
4-sulfated GalNAc + 2-sulfated
IdoA in ascidian DSc
Sulfation content in red algal
homogeneous SGsd
4-sulfation in invertebrate 3-linked
SFse
Enhance HCII-dependent IIa inhibition
a(Pereira et al., 2005a).
b(Fonseca et al., 2009).
c (Pavão et al., 1998).
d (Pereira et al., 2005b).
e(Pereira et al., 2002).
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performed on samples of similar molecular weights. This pro-
cedure disregards the contribution from differential molecular
weights.
One of the major goals of research programs involved with
drug development nowadays, especially those related with poten-
tial carbohydrate-based drug candidates, is to understand the
structural requirements of the new compounds in their specific
therapeutic functions. Here, we have presented in a clear and
straightforward way some of these structural requirements of the
invertebrate and red algal SPs for their anticoagulant properties.
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